GlassScriptPhysician profile
Rameshchandra D Patel
NPI 1356563027
$5,173.35
in general payments reported to CMS, 2019-2025
16 companies · $1,992 in 2025
The $1,992 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $192 · 2021: $339 · 2022: $685 · 2023: $860 · 2024: $982 · 2025: $1,992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,697 · Entertainment: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,696.61 |
| Entertainment | $137.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $831.29 | 2020-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $792.48 | 2021-2025 | Acuvue |
| Coopervision INC. | $756.53 | 2023-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Harrow Eye, LLC | $559.82 | 2024-2025 | Vevye |
| Alcon Vision LLC | $538.29 | 2020-2025 | Rocklatan, Tryptyr, Precision7 |
| Bausch & Lomb Americas INC. | $408.85 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $279.91 | 2019-2021 | |
| Dompe US, INC. | $214.46 | 2022-2024 | Oxervate |
| Rxsight INC | $154.00 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Glaukos Corporation | $147.33 | 2023 | |
| Optos, INC. | $137.51 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tarsus Pharmaceuticals, INC. | $121.82 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $117.63 | 2022 | |
| Kala Pharmaceuticals, INC. | $52.41 | 2022 | |
| Novartis Pharmaceuticals Corporation | $41.61 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $19.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rameshchandra Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.